InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Thompson Tommy G, Director. Insider active across 4 companies, notably TherapeuticsMD, Inc.. Aggregated, 21 reports have been published. Total volume traded: €25k. The latest transaction was disclosed on 26 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations21 total
€98,6142,200 shares@ €44.82460.0004% mcap24.4% of flow
Common Stock
SEC:0001415889-22-005733:0·
€65,0631,500 shares@ €43.37550.0003% mcap16.1% of flow
Common Stock
SEC:0001415889-22-003475:0·
€65,7881,500 shares@ €43.85850.0003% mcap16.3% of flow
Common Stock
SEC:0001415889-22-003191:0·
€65,9451,500 shares@ €43.96340.0003% mcap16.3% of flow
Common Stock
SEC:0001415889-22-003050:0·
€43,4451,000 shares@ €43.44480.0002% mcap10.8% of flow
Common Stock
SEC:0001415889-22-002893:0·
€64,9411,500 shares@ €43.29420.0003% mcap16.1% of flow
Common Stock
SEC:0001415889-22-002547:0·
4,358 shares
Common shares, $0.01 par value
SEC:0001574540-22-000053:0·
0450.241 shares0
Common Stock
SEC:0001071739-22-000009·
0450.241 shares0
Common Stock
SEC:0001071739-22-000009:0·
€30,239523.795 shares@ €57.73050.0001% mcap50.6% of flow
Common Stock
SEC:0001071739-21-000213·
€30,239523.795 shares@ €57.73050.0001% mcap25.3% of flow
Common Stock
SEC:0001071739-21-000213:0·
€8,15411,000 shares@ €0.74130.035% mcap65.0% of flow
Common Stock
SEC:0001387131-21-008639·
Ideal exit: 10 May 2022 (T+270)
€8,15411,000 shares@ €0.74130.035% mcap32.5% of flow
Common Stock
SEC:0001387131-21-008639:0·
Ideal exit: 10 May 2022 (T+270)
145,296 shares
Common Stock
SEC:0001387131-21-008435·
145,296 shares
Common Stock
SEC:0001387131-21-008435:0·
€29,519510.874 shares@ €57.78130.0001% mcap49.4% of flow
Common Stock
SEC:0001071739-21-000173·
€29,519510.874 shares@ €57.78130.0001% mcap24.7% of flow
Common Stock
SEC:0001071739-21-000173:0·
01,680 shares0
Common Stock
SEC:0001127602-21-020805·
01,680 shares0
Common Stock
SEC:0001127602-21-020805:0·
€4,3885,000 shares@ €0.87770.019% mcap35.0% of flow
Common Stock
SEC:0001387131-21-005770·
Ideal exit: 8 Feb 2022 (T+270)
€4,3885,000 shares@ €0.87770.019% mcap17.5% of flow
Common Stock
SEC:0001387131-21-005770:0·
Ideal exit: 8 Feb 2022 (T+270)
21 of 21 declarations
About Thompson Tommy G
Tommy G Thompson is an executive at TherapeuticsMD, Inc.
